Frog lung cathelicidin AS34 shows potent broad-spectrum antimicrobial and anti-inflammatory effects
Background
Amphibians, with their dual aquatic-terrestrial lifestyles, have evolved sophisticated innate immune mechanisms, including a rich repertoire of host defense peptides. Cathelicidins are crucial effectors of this innate immunity, known for their dual antimicrobial and immunomodulatory functions. While human LL-37 and rodent CRAMP are well-studied, the full diversity and specific functions of pulmonary cathelicidins in amphibians remain incompletely characterized. Understanding these unique peptides could reveal novel therapeutic strategies for combating infectious diseases and inflammatory conditions, addressing limitations of current antibiotics and anti-inflammatory drugs.
Study Design
Researchers conducted an integrated transcriptomic and biochemical analysis of lung-expressed cathelicidins in the tiger frog (Hoplobatrachus rugulosus). RNA sequencing of lung tissue identified four cathelicidin paralogs: Hr-CATH1 to Hr-CATH4 (AS34, SN34, AR37, DL37). RT-qPCR confirmed their expression patterns. Bioinformatic analysis characterized their physicochemical properties. Circular dichroism spectroscopy assessed membrane-induced α-helical adoption. Biological activity assays evaluated antimicrobial potency against various microorganisms, and immunomodulatory effects were tested by measuring nitric oxide production in RAW264.7 macrophages stimulated with lipopolysaccharide (LPS), alongside pro-inflammatory gene expression (TNF-α, IL-1β, IL-6, iNOS, COX-2). Hemolytic efficacy was also assessed.
Results
The study identified four distinct cathelicidin paralogs (AS34, SN34, AR37, DL37) co-expressed in the frog lung, exhibiting substantial variation in physicochemical properties, from highly cationic (+9 for AS34) to anionic (-4 for DL37). Circular dichroism confirmed membrane-induced α-helical adoption across all peptides. Biological activity assays revealed diverse functional profiles: AS34 exhibited potent broad-spectrum antimicrobial potency, consistent with membrane disruption and DNA binding. SN34 displayed moderate selective antimicrobial activity, while AR37 and DL37 lacked direct antimicrobial effects. Notably, all four peptides suppressed lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophages. AS34 further downregulated pro-inflammatory gene expression, including TNF-α, IL-1β, IL-6, iNOS, and COX-2. Hemolytic efficacy was low to moderate at high concentrations. > AS34 demonstrated potent broad-spectrum antimicrobial activity and significantly suppressed LPS-induced inflammation by downregulating key pro-inflammatory genes, highlighting its multifaceted defense role.
Key Findings
- Four distinct cathelicidin paralogs (AS34, SN34, AR37, DL37) were identified in Hoplobatrachus rugulosus lung.
- AS34 exhibited potent broad-spectrum antimicrobial activity, consistent with membrane disruption and DNA binding.
- All four cathelicidin peptides suppressed
lipopolysaccharide-inducednitric oxideproduction inRAW264.7 macrophages. - AS34 significantly downregulated pro-inflammatory gene expression (
TNF-α,IL-1β,IL-6,iNOS,COX-2). - Peptides showed low to moderate hemolytic efficacy only at high concentrations.
Why It Matters
This research significantly expands our understanding of amphibian pulmonary innate immunity and identifies AS34 as a promising scaffold for developing novel antimicrobial and anti-inflammatory therapeutics. For peptide users and biohackers, this highlights the potential of exploring diverse natural sources for compounds with dual therapeutic benefits, especially in an era of increasing antibiotic resistance and chronic inflammatory conditions. The detailed characterization of AS34's potent effects suggests it could inspire new drug designs that simultaneously combat infection and modulate detrimental inflammation. While currently a preclinical finding, it paves the way for future studies to optimize its structure and delivery, potentially leading to a usable protocol for human applications, perhaps as a topical agent or inhaled therapeutic for lung-related issues.
cathelicidin
as34
antimicrobial
anti-inflammatory
innate-immunity
frog